Health Research Institute.
Faculty of Education, Science, Technology, and Mathematics, and.
Am J Clin Nutr. 2017 Aug;106(2):519-529. doi: 10.3945/ajcn.116.145169. Epub 2017 Jun 7.
Conflicting evidence exists on the role of long-term fructose consumption on health. No systematic review has addressed the effect of isoenergetic fructose replacement of other sugars and its effect on glycated hemoglobin (HbA1c), fasting blood glucose, insulin, and triglycerides. The objective of this study was to review the evidence for a reduction in fasting glycemic and insulinemic markers after chronic, isoenergetic replacement of glucose or sucrose in foods or beverages by fructose. The target populations were persons without diabetes, those with impaired glucose tolerance, and those with type 2 diabetes. We searched the Cochrane Library, MEDLINE, EMBASE, the WHO International Clinical Trials Registry Platform Search Portal, and clinicaltrials.gov The date of the last search was 26 April 2016. We included randomized controlled trials of isoenergetic replacement of glucose, sucrose, or both by fructose in adults or children with or without diabetes of ≥2 wk duration that measured fasting blood glucose. The main outcomes analyzed were fasting blood glucose and insulin as well as fasting triglycerides, blood lipoproteins, HbA1c, and body weight. We included 14 comparison arms from 11 trials, including 277 patients. The studies varied in length from 2 to 10 wk (mean: 28 d) and included doses of fructose between 40 and 150 g/d (mean: 68 g/d). Fructose substitution in some subgroups resulted in significantly but only slightly lowered fasting blood glucose (-0.14 mmol/L; 95% CI: -0.24, -0.036 mmol/L), HbA1c [-10 g/L (95% CI: -12.90, -7.10 g/L; impaired glucose tolerance) and -6 g/L (95% CI: -8.47, -3.53 g/L; normoglycemia)], triglycerides (-0.08 mmol/L; 95% CI: -0.14, -0.02 mmol/L), and body weight (-1.40 kg; 95% CI: -2.07, -0.74 kg). There was no effect on fasting blood insulin or blood lipids. The evidence suggests that the substitution of fructose for glucose or sucrose in food or beverages may be of benefit to individuals, particularly those with impaired glucose tolerance or type 2 diabetes. However, additional high-quality studies in these populations are required.
关于长期果糖摄入对健康的影响,现有证据相互矛盾。尚无系统评价专门探讨等能量果糖替代其他糖对糖化血红蛋白(HbA1c)、空腹血糖、胰岛素和甘油三酯的影响。本研究旨在综述慢性等能量替代食物或饮料中的葡萄糖或蔗糖为果糖后空腹血糖和胰岛素标志物降低的证据。目标人群为无糖尿病者、糖耐量受损者和 2 型糖尿病患者。我们检索了 Cochrane 图书馆、MEDLINE、EMBASE、世界卫生组织国际临床试验注册平台搜索门户和 clinicaltrials.gov,检索日期截至 2016 年 4 月 26 日。纳入了在≥2 周时间内用果糖等能量替代葡萄糖、蔗糖或两者的成人或儿童的随机对照试验,且测量了空腹血糖。主要分析的结局是空腹血糖和胰岛素以及空腹甘油三酯、血脂、HbA1c 和体重。我们纳入了 11 项试验的 14 个对照臂,共 277 名患者。研究持续时间为 2 至 10 周(平均:28 天),果糖剂量为 40 至 150 g/d(平均:68 g/d)。在某些亚组中,果糖替代导致空腹血糖显著但仅轻度降低(-0.14 mmol/L;95%CI:-0.24,-0.036 mmol/L)、HbA1c 降低(糖耐量受损者-10 g/L(95%CI:-12.90,-7.10 g/L)和正常血糖者-6 g/L(95%CI:-8.47,-3.53 g/L))、甘油三酯降低(-0.08 mmol/L;95%CI:-0.14,-0.02 mmol/L)和体重降低(-1.40 kg;95%CI:-2.07,-0.74 kg)。空腹胰岛素或血脂无变化。证据表明,用果糖替代食物或饮料中的葡萄糖或蔗糖可能对个体有益,尤其是糖耐量受损者或 2 型糖尿病患者。但是,这些人群还需要更多高质量的研究。